Drugs / Pola
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07552324 | May 2026 → May 2027 expected | T-cell/histiocyte rich large B cell lymphoma | Ruijin Hospital | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pola | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07552324 ↗ |